H2QXF0 (H2QXF0_PANTR) Pan troglodytes (Chimpanzee)

Cathepsin L UniProtKBInterProSTRINGInteractive Modelling

333 aa; Sequence (Fasta) ; 3 identical sequences: Homo sapiens: P07711; Pan troglodytes: A0A6D2WE91; Pan paniscus: A0A2R9ACG6

Available Structures

64 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of cysteine protease inhibitor, chagasin, in complex with human cathepsin L
2nqd
 Heteromer
P07711; Q966X9; 		113-333
1×NAG; 1×NA; 1×CL;
Assess
Unreduced cathepsin L in complex with stefin A
3kse
 Heteromer
P01040; P07711; 		114-333
Assess
CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L
1icf
 Heteromer
P04233; P07711; 		114-333
1×NAG;
Assess
Cathsilicatein, a chimera
2vhs
homo-4-mer114-333
8×SO4;
Assess
Crystal structure of human cathepsin L in complex with the vinyl sulfone inhibitor K777
8qkb
homo-4-mer114-333
4×D1R; 1×PG4; 12×EDO; 5×PEG; 6×DMS; 3×PGE;
Assess
Crystal structure of human cathepsin L after reaction with the bound ketoamide inhibitor 13b
8prx
homo-4-mer114-333
4×KH0; 11×DMS; 8×PEG; 1×PG4; 10×EDO; 3×PGE;
Assess
Caught in the Act: The Crystal Structure of cleaved Cathepsin L bound to the active site of Catheps…
5i4h
homo-2-mer113-333
4×SO4; 2×GOL;
Assess
CATHEPSIN L IN COMPLEX WITH AC1115
8uac
homo-2-mer114-333
2×W28;
Assess
Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized …
1mhw
homo-2-mer114-333
Assess
HUMAN CATHEPSIN L APO FORM WITH ZN
4axl
homo-2-mer114-333
2×ZN; 2×GOL; 2×ACT;
Assess
Crystal structure of mature apo-Cathepsin L C25A mutant
3iv2
homo-2-mer114-333
1×NAG; 5×GOL; 4×SO4; 1×NA;
Assess
CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-17-oxa-4-azatricyclo[16…
6ezx
homo-2-mer114-333
2×C7Q;
Assess
Structure of a proline specific mutant of human cathepsin L
6jd8
monomer18-333
1×GOL; 12×EOH; 1×PEG; 1×EDO; 1×PGE;
Assess
CRYSTAL STRUCTURE OF PROCATHEPSIN L
1cs8
monomer18-333
Assess
Structure of mutant human cathepsin L, engineered for GAG binding
6jd0
monomer18-333
14×GOL; 3×CL; 5×NA; 8×PO4; 10×POL; 6×PGE; 3×EOH; 2×EDO;
Assess
CRYSTAL STRUCTURE OF A CYSTEINE PROTEASE PROFORM
1cjl
monomer22-333
Assess
Structural Basis for Irreversible Inhibition of Human Cathepsin L by a Diazomethylketone Inhibitor
3of9
monomer113-333
1×I0X;
Assess
Structural Basis for Reversible and Irreversible Inhibition of Human Cathepsin L by their Respectiv…
3of8
monomer113-333
1×I0Y;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2xu3
monomer114-333
1×XU3; 2×BTB; 1×CL;
Assess
CATHEPSIN L IN COMPLEX WITH 4-[cyclopentyl(imidazo[1,2-a]pyridin-2-ylmethyl)amino]-6-morpholino-1,3…
5maj
monomer114-333
1×7KH; 1×EDO;
Assess
CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-Chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2…
5mae
monomer114-333
1×7KN; 4×EDO;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2xu4
monomer114-333
1×DJT; 2×GOL;
Assess
CATHEPSIN L IN COMPLEX WITH 4-[1,3-benzodioxol-5-ylmethyl(2-phenoxyethyl)amino]-5-fluoropyrimidine-…
5mqy
monomer114-333
1×GH4; 8×EDO;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2yjc
monomer114-333
1×424;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2yj2
monomer114-333
1×YJ2; 1×GOL;
Assess
Crystal structure of cathepsin L in complex with AZ12878478
3hha
monomer114-333
1×NOW; 1×PG4; 1×ACT;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2yj8
monomer114-333
1×YJ8; 1×GOL;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2yj9
monomer114-333
1×YJ9; 1×GOL;
Assess
Crystal structure of human Cathepsin L in complex with covalently bound Calpeptin
7z58
monomer114-333
2×PEG; 2×PGE; 1×EDO; 1×RN2;
Assess
CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyc…
6ezp
monomer114-333
1×C3E; 2×GOL;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2yjb
monomer114-333
1×YJ9; 1×GOL;
Assess
Crystal structure of human cathepsin L with covalently bound Cathepsin L inhibitor IV
8a4w
monomer114-333
1×L2F; 1×PEG; 1×EDO; 2×DMS;
Assess
CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-Chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2…
5f02
monomer114-333
1×GOL; 1×5T9;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2xu1
monomer114-333
1×424;
Assess
Crystal structure of human Cathepsin L in complex with covalently bound MG132
7qkd
monomer114-333
1×ALD; 2×PEG;
Assess
Crystal structure of human cathepsin L with covalently bound calpain inhibitor VI
7zs7
monomer114-333
1×JQO; 2×DMS;
Assess
CATHEPSIN L WITH A NITRILE INHIBITOR
2xu5
monomer114-333
1×XU5; 1×GOL; 1×FLC;
Assess
Crystal structure of human cathepsin L with covalently bound aloxistatin (E-64D)
7zxa
monomer114-333
1×E6D; 1×1PE; 1×PG4; 1×DMS; 1×PEG; 2×PGE; 1×EDO;
Assess
Crystal structure of human cathepsin L in complex with covalently bound CLIK148
7zvf
monomer114-333
1×KXL; 1×PG4; 1×1PE; 2×DMS; 3×PEG;
Assess
Crystal structure of apo human Cathepsin L
7z3t
monomer114-333
3×PEG; 1×PGE; 1×EDO;
Assess
Crystal structure of human cathepsin L with covalently bound E-64
8a4v
monomer114-333
1×E64; 2×PEG;
Assess
Crystal structure of human Cathepsin L after incubation with Sulfo-Calpeptin
7qkc
monomer114-333
2×PEG; 1×RN2;
Assess
Human cathepsin L after reaction with the thiocarbazate inhibitor CID 16725315
8c77
monomer114-333
1×TXH; 4×EDO; 1×PG4;
Assess
Crystal structure of human cathepsin L in complex with calpain inhibitor XII
8ahv
monomer114-333
2×PGE; 1×M6L; 1×DMS;
Assess
Crystal structure of human Cathepsin L in complex with covalently bound GC376
7qkb
monomer114-333
2×PEG; 1×NA; 1×PGE; 1×CL; 1×UED;
Assess
Human cathepsin L in complex with covalently bound CA-074 methyl ester
8oza
monomer114-333
1×WRH; 1×PEG; 2×EDO;
Assess
Crystal structure of human cathepsin L in complex with covalently bound MG-101
8a5b
monomer114-333
1×PGE; 1×NA;
Assess
A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors(co…
3h8b
monomer114-333
1×NSY;
Assess
Crystal structure of human Cathepsin L with covalently bound Calpain inhibitor III
8a4x
monomer114-333
1×L3F; 1×PEG; 1×PGE; 1×PG4;
Assess
Crystal structure of human cathepsin L interacting with tosyl phenylalanyl chloromethyl ketone (TPC…
8ofa
monomer114-333
1×TQ8; 1×EDO; 2×PEG; 3×DMS; 1×PGE; 1×PG5; 1×VLF;
Assess
Crystal structure of human cathepsin L with CAA0225
8a4u
monomer114-333
1×L2X; 2×NA; 5×PEG;
Assess
Crystal structure of human cathepsin L forming a thiohemiacetal with N-Boc-2-aminoacetaldehyde
8b4f
monomer114-333
1×OYU; 1×PGE; 1×DMS; 2×EDO; 1×PEG; 2×NA;
Assess
The crystal structure of human CtsL in complex with 14c
8gx2
monomer114-333
2×DMS; 1×KJ0;
Assess
Crystal structure of CTSL in complex with E64d
8het
monomer114-333
1×E6D;
Assess
CATHEPSIN L IN COMPLEX WITH (3S,14E)-8-(azetidin-3-yl)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17…
6f06
monomer114-333
1×C7T; 6×ZN; 1×CL;
Assess
Crystal structure of CTSL in complex with K777
8hfv
monomer114-333
7×ZN; 2×CAC; 1×0IW;
Assess
Exploring inhibitor binding at the S subsites of cathepsin L
3bc3
monomer114-333
1×OPT;
Assess
CATHEPSIN L with AZ13010160
3hwn
monomer114-333
1×BD3;
Assess
The crystal structure of human CtsL in complex with 14a
7w33
monomer114-333
1×89B;
Assess
Crystal structure of mature apo-Cathepsin L C25A mutant in complex with Gln-Leu-Ala peptide
3k24
monomer114-333
1×NAG;
Assess
A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors(co…
3h89
monomer114-333
1×NSX;
Assess
A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors (c…
3h8c
monomer114-333
1×NSZ;
Assess
TRIAZINE CATHEPSIN INHIBITOR COMPLEX
4axm
monomer114-333
1×GOL; 1×V65;
Assess
The crystal structure of human CtsL in complex with 14b
7w34
monomer114-333
1×89K;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6jd8.1.Amonomer0.8718-333
98.42
Assess